Angiotensin-converting enzyme inhibitor suppresses tubular expression of platelet-derived growth factor and attenuates progression of tubulo-interstitial fibrosis in a nephrotic mouse model [17]

Nephron

Volumn 79, Issue 4, 1998, Pages 503-504

  Mizuno, S ^a   Mizuno Horikawa, Y ^a   Okamoto, M ^a   Kurosawa, T ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENALAPRIL MALEATE; GROWTH FACTOR; MATRIX PROTEIN; PLATELET DERIVED GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; EPITHELIUM CELL; FEMALE; HEMODYNAMICS; HISTOPATHOLOGY; INTERSTITIAL NEPHRITIS; KIDNEY FIBROSIS; KIDNEY TUBULE; LETTER; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; UREA NITROGEN BLOOD LEVEL; URINE LEVEL;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ENALAPRIL; FIBRONECTINS; KIDNEY TUBULES; MICE; MICE, INBRED STRAINS; NEPHRITIS, INTERSTITIAL; NEPHROSIS; PLATELET-DERIVED GROWTH FACTOR;

EID: 0031849198     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045112     Document Type: Letter

References (6)